Literature DB >> 2846970

Effects of magnesium on calcium phosphate formation.

P T Cheng1, J J Grabher, R Z LeGeros.   

Abstract

All biological calcium phosphates form in various neutral aqueous solutions containing [CaCl2] = 1 or 3 mM, [MgCl2] = 0-9 mM, [Na2HPO4] = 0.1-90 mM and NaCl (total 300 mosM) kept quiescently at 37 degrees C for 21 days. In all solutions containing 1 mM Ca and in solutions with [Ca] = 3 mM and [PO4] less than 10 mM, heterogeneous nucleation of octa-calcium phosphate (for Mg/Ca less than or equal to 1) or brushite (for Mg/Ca greater than 1) was observed; the former transforming to apatite with time. In contrast, homogeneous nucleation of an unstable amorphous calcium magnesium phosphate occurred in solutions with [Ca] = 3 mM and [PO4] greater than or equal to 10 mM, transforming to apatite, to brushite, and to whitlockite (and newberyite) depending on Mg/Ca and [PO4] values.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846970

Source DB:  PubMed          Journal:  Magnesium        ISSN: 0252-1156


  13 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

Review 2.  Calcium orthophosphates: crystallization and dissolution.

Authors:  Lijun Wang; George H Nancollas
Journal:  Chem Rev       Date:  2008-09-25       Impact factor: 60.622

3.  Template-free synthesis of phosphate-based spheres via modified supersaturated phosphate buffer solutions.

Authors:  Tao Qin; Yuanyuan Han; Peng Zhang; Ishtiaq Hassan Wani; Fredrik Nikolajeff; Klaus Leifer; Håkan Engqvist
Journal:  J Mater Sci Mater Med       Date:  2017-05-22       Impact factor: 3.896

Review 4.  Magnesium and cardiovascular complications of chronic kidney disease.

Authors:  Ziad A Massy; Tilman B Drüeke
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 5.  Clinical features of CKD-MBD in Japan: cohort studies and registry.

Authors:  Takayuki Hamano; Yusuke Sakaguchi; Naohiko Fujii; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801

6.  Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour.

Authors:  Elena Landi; Giandomenico Logroscino; Luca Proietti; Anna Tampieri; Monica Sandri; Simone Sprio
Journal:  J Mater Sci Mater Med       Date:  2007-06-28       Impact factor: 3.896

7.  Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.

Authors:  Ziad A Massy; Tilman B Drüeke
Journal:  Clin Kidney J       Date:  2012-02

Review 8.  Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Yoshitaka Isaka
Journal:  Nutrients       Date:  2017-02-06       Impact factor: 5.717

9.  Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis.

Authors:  Chao Zeng; Jie Wei; Robert Terkeltaub; Tuo Yang; Hyon K Choi; Yi-Lun Wang; Dong-Xing Xie; David J Hunter; Yuqing Zhang; Hui Li; Yang Cui; Liang-Jun Li; Guang-Hua Lei
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

10.  Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Chikako Nakano; Yoshitsugu Obi; Isao Matsui; Yasuo Kusunoki; Daisuke Mori; Tatsufumi Oka; Nobuhiro Hashimoto; Yoshitsugu Takabatake; Atsushi Takahashi; Jun-Ya Kaimori; Toshiki Moriyama; Ryohei Yamamoto; Masaru Horio; Ken Sugimoto; Koichi Yamamoto; Hiromi Rakugi; Yoshitaka Isaka
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.